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Is the risk of cerebral injury following trans­
carotid TAVI as high as it was claimed before? 
To answer this question, we conducted a single­
­center, observational preliminary study. The ob­
jective was to compare brain magnetic resonance 
imaging (MRI) scans in patients undergoing TAVI 
through transfemoral and transcarotid approach­
es and assess their declared quality of life and 
cognitive functioning in a 3­month follow ­up.
Methods A nonrandomized study included 
8 consecutive patients with severe, symptom­
atic aortic stenosis. Patients disqualified from 
the transfemoral access were considered for 
transcarotid TAVI. Patients with existing contra­
indications for MRI were excluded from the study.
Five patients underwent transfemoral TAVI 
and 3 patients underwent TAVI via carotid ac­
cess. The process of qualification included phys­
ical examination, computed tomography angi­
ography, and an interview with the patient and 
his relatives. Carotid Doppler was performed in 
all patients disqualified from the transfemoral 
approach to assess the possibility of an alterna­
tive access. The mean (SD) age in both groups 
was 83 (3.16) years; all patients had compara­
ble comorbidities. In the transcarotid group, 2 
out of 3 patients and in the transfemoral group, 
1 out of 5 patients presented chronic atrial fi­
brillation. The mean Society of Thoracic Sur­
geons risk score for both groups was 9.9%, and 
for transfemoral and transcarotid TAVI, 8.98% 
vs 11.44%, respectively.
All TAVI procedures were performed by a local 
Heart Team in a hybrid operating room equipped 
with a heart ­lung machine on stand ­by. The 
Introduction In 2010, the first case of trans­
catheter aortic valve implantation (TAVI) via 
the left carotid artery was presented in liter­
ature. Modine et al1 described the method as 
“the last resort” in case of unavailability of oth­
er possible approaches and pointed out that it 
should be preceded by a careful cerebral arteri­
al assessment.
Until today, the great majority of procedures 
are still performed through a transfemoral ap­
proach. Of note, transfemoral TAVI may be ob­
tained with a complete percutaneous approach 
or surgical access, which both have been shown 
to have similar safety and efficacy.2 Due to par­
ticular circumstances such as severe peripher­
al atherosclerosis and calcified vessels, signif­
icant descending aortic disease or physiologi­
cal abnormalities of the vasculature, this path­
way cannot always be performed and may not 
be the best option for the patient. On the other 
hand, transthoracic approaches are well known 
to be associated with higher mortality,3 there­
fore carotid access was suggested as the prom­
ising alternative.
Unfortunately, manipulation of the cathe­
ter in the carotid artery may be associated with 
an increased risk of cerebral injury. Nevertheless, 
the analysis of literature showed that the trans­
carotid TAVI procedure is similar to the trans­
femoral approach for mortality and morbidity.4,5 
Moreover, the prevalence of neurological inju­
ry in transcarotid TAVI does not differ signifi­
cantly from the existing data on transfemoral 
access.6,7 The chances are that the transcarotid 
TAVI procedure may be a propitious and attrac­
tive alternative to the current gold standard.
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lesions, up to 7 mm, in both hemispheres and 
the cerebellum (FiGURe 1A-1D). There were no recent 
lesions in the following 2 patients’ scans. In 
the transcarotid group, there were no lesions 
found after the procedure, except for one pa­
tient with a single acute 4­mm ischemic lesion 
in the precentral gyrus, which was not signifi­
cant clinically. The lesion was located in the left 
hemisphere, ipsilaterally to the used carotid ar­
tery. Three patients with lesions from the trans­
femoral group presented mild post ­operative 
delirium symptoms, approximately 3 days af­
ter TAVI. One of them required the administra­
tion of antipsychotic medication.
Furthermore, the quality of life was evaluated 
using the Polish version of the EQ­5D­3L ques­
tionnaire and the screening of cognitive func­
tioning was assessed with the Montreal Cogni­
tive Assessment. The follow ­up evaluation was 
performed after 3 months from the procedure 
in an outpatient clinic setting. The great major­
ity of patients in both groups declared a signifi­
cant improvement in the quality of life, includ­
ing pain or discomfort and depression or anxi­
ety symptoms. The screening of cognitive func­
tioning did not show any significant results. Pa­
tient scores were minimally lower or similar to 
the baseline results.
The presented preliminary study compared 
brain MRI scans of 2 groups of patients who un­
derwent TAVI through transfemoral and trans­
carotid approaches. None of acute ischemic le­
sions had any significant clinical consequenc­
es on the patients’ wellbeing in the 3­month 
follow ­up. Moreover, chronic atrial fibrillation 
did not seem to be a risk factor of ischemia fol­
lowing TAVI. Taking into account the Valve Ac­
ademic Research Consortium 2 definitions of 
stroke, all patients with cerebral ischemic le­
sions underwent nondisabling stroke (modi­
fied Rankin Scale; mRS <2 at 90 days or no in­
crease in mRS ≥1 from the prestroke baseline).8
The preliminary data may suggest that patients 
undergoing TAVI in both described approaches are 
not exposed to severe cerebral injury. Therefore, 
Evolut R valve (Medtronic, Minneapolis, Minne­
sota, United States) was implanted in all patients.
Transcarotid implantations were performed 
under general anesthesia using the left carot­
id artery. In order to expose the carotid artery, 
an approximately 5­cm vertical incision above 
the clavicle was performed.
Transfemoral implantations were done un­
der local anesthesia without any sedation. Vas­
cular access was performed percutaneously and 
in all cases, percutaneous vascular closure de­
vices were used.
In both groups, the position of the prosthesis 
was confirmed using a contrast medium. A fur­
ther bolus of contrast medium was given after 
the procedure to evaluate the position of the valve 
and to estimate the eventual paravalvular leak 
and coronary ostia. After estimating the shape 
of the valve and paravalvular leak, the decision 
whether to perform post ­dilatation was made.
Furthermore, all patients underwent non­
contrast magnetic resonance brain imaging be­
fore and 3 to 5 days after the procedure, in order 
to assess the number of potential recent isch­
emic lesions.
All patients were able to and signed an in­
formed consent form. The study design was ap­
proved by the Bioethics Committee of the Med­
ical University of Gdańsk.
Statistical analysis The statistical analysis was 
performed using STATISTICA 12.0 PL (StatSoft, 
Kraków, Poland), yet due to the small number of 
patients, the analysis was not presented. More­
over, the analysis included basic statistical con­
cepts such as means, medians (SD).
Results and discussion The procedures were 
performed without any complications and 
the mean hospital stay for both groups was ap­
proximately 5 days. Echocardiographic param­
eters were improving in comparison with base­
line values.
In the transfemoral group, 3 patients’ MRI 
scans showed several minor recent ischemic 
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Figure 1 Diffusion-weighted magnetic resonance imaging: A, B – no acute ischemic brain lesions before transfemoral transcatheter aortic valve implantation; 
C, D – acute ischemic brain lesions in the head of the caudate nucleus and in the left brain hemisphere (arrows) after transfemoral transcatheter aortic valve implantation
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we should consider transcarotid access as a prom­
ising alternative to transfemoral approach. First 
of all, transcarotid pathway presents a direct and 
significantly shorter route to the aortic valve from 
the entry. The additional benefit is an improved 
movement precision of catheter delivery.
Furthermore, the role of patient qualifica­
tion is integral to the procedure’s success. All pa­
tients considered for transcarotid access should 
undergo a detailed interview and transcarotid 
Doppler. Moreover, the assessment of calcium 
score should be an important part of computed 
tomography angiography in every patient. It can 
potentially be associated with higher risk of isch­
emic injury in TAVI. If the score raises doubts, 
it may be more adequate to choose nonvascu­
lar type of access and / or to use neuroprotec­
tive devices. The role of pre­ and post ­dilatation 
may be also connected with potential ischemic 
lesions, regardless of the type of access. Fur­
ther, we have to reconsider the method of eval­
uating cognitive functioning and quality of life 
to make it more suitable and sensitive for this 
specific group of elderly patients.
Summarizing, despite the acute, mainly not sig­
nificant clinically ischemic lesions, the quality of 
life was improving in both types of access. These 
preliminary results suggest that it is very possible 
that transcarotid access is safe and not connect­
ed with a higher risk of neurological injury. Fur­
ther studies are needed to prove that hypothesis.
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